Posts

Fordham 27 (Report 13): PTAB

Does Allergan's Saint Regis Mohawk Tribe transactional move "rip off consumers"?

ChIPs Global Summit Report 3: Congratulations - your patent has been allowed, when is it finally final?

AIPPI Congress Report 3: Biosimilars – similar but different?

US Supreme Court Accepts USPTO "Death Squad (?)" "Broadest Reasonable Construction" Standard

Intellectual Property Challenges in the Bio-Pharmaceutical Field

Hedge funds, pharma patents and thorny issues: a word on IPRs following Lialda

Letter from AmeriKat: No CAFC hearing for Samsung, Apple top patent litigation target & TPP's copyright conundrum